Development Level

Tbio 2 | 10,625
Tchem 2 | 1,890

Disease

Alcohol dependence 3 | 107
Alzheimer's disease 3 | 644
Anxiety Disorders 3 | 37
Cancer 3 | 2,346
Cocaine-Related Disorders 3 | 88
Epilepsy 3 | 346
Hypertension 3 | 287
Major Depressive Disorder 3 | 106
Obesity 3 | 616
glioblastoma 3 | 5,572
medulloblastoma, large-cell 3 | 6,234
oligodendroglioma 3 | 2,849
psoriasis 3 | 6,685
Anorexia 2 | 15
Anorexia nervosa 2 | 59
Asthma 2 | 349
Depressive disorder 2 | 48
Fibromyalgia 2 | 22
Huntington's disease 2 | 72
Hyperactive behavior 2 | 31
Hypoglycemia 2 | 81
Inflammatory bowel disease 2 | 142
Irritable bowel syndrome 2 | 59
Migraine 2 | 79
Pain agnosia 2 | 99
Pick disease 2 | 1,893
Rhinitis 2 | 46
Schizophrenia 2 | 501
Seizures 2 | 95
Substance Withdrawal Syndrome 2 | 52
Weight decreased 2 | 18
Withdrawal disorder 2 | 19
astrocytic glioma 2 | 2,241
atypical teratoid / rhabdoid tumor 2 | 4,369
chronic kidney disease 2 | 90
diabetes mellitus 2 | 1,663
ependymoma 2 | 2,514
osteosarcoma 2 | 7,933
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
post-traumatic stress disorder 2 | 45
sonic hedgehog group medulloblastoma 2 | 1,482
Acromegaly 1 | 40
Acute lymphocytic leukemia 1 | 18
Adenoma 1 | 165
Adrenal adenoma 1 | 5
Alcoholic Intoxication, Chronic 1 | 41
Alopecia 1 | 55
Amenorrhea 1 | 60
Anxiety disorder 1 | 22
Atypical depressive disorder 1 | 6
Autistic Disorder 1 | 320
Bipolar Disorder 1 | 266
Bradycardia 1 | 24
Bronchitis, Chronic 1 | 9
Bulimia nervosa 1 | 15
Cerebrovascular disease 1 | 231
Chronic fatigue syndrome 1 | 29
Complex regional pain syndrome 1 | 12
Cushing's syndrome 1 | 47
Dementia 1 | 129
Dermatitis 1 | 107
Eating disorder 1 | 24
Epicondylitis 1 | 19
Epilepsy, Temporal Lobe 1 | 23
Gastrointestinal system disease 1 | 50
Generalized anxiety disorder 1 | 29
Heart disease 1 | 279
Hepatitis C 1 | 90
Hyperglycemia 1 | 120
Hyperinsulinism 1 | 63
Hypopituitarism 1 | 36
Hypotension 1 | 53
Hypothyroidism 1 | 89
Kidney failure 1 | 39
Leukopenia 1 | 42
Melancholia 1 | 12
Memory Disorders 1 | 36
Metabolic syndrome X 1 | 155
Movement Disorders 1 | 21
Muscle Rigidity 1 | 5
Narcolepsy 1 | 58
Neuropathy 1 | 210
Neutropenia 1 | 78
Osteoporosis 1 | 257
Pain 1 | 70
Panic disorder 1 | 55
Parkinson's disease 1 | 364
Periodontal disease 1 | 37
Phaeochromocytoma 1 | 20
Pituitary adenoma 1 | 35
Psychomotor Disorders 1 | 7
Retinitis 1 | 9
Rosacea 1 | 18
Status Epilepticus 1 | 85
Stereotypic movement disorder 1 | 6
Substance abuse 1 | 55
Substance-Related Disorders 1 | 114
West Syndrome 1 | 23
atypical teratoid/rhabdoid tumor 1 | 1,095

Tissue

Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Nervous System 4 | 18,561
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444
Blood and immune system 2 | 17,995

Target Family

Non-IDG 3 | 11,971
Enzyme 1 | 4,146

Grant Application

1S10RR014593-01 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Thiopurine S-methyltransferase TPMT Tchem Enzyme -2.20504 171.7 245
Corticoliberin CRH Tbio Non-IDG -3.72173 5615.4 346
Pro-neuropeptide Y NPY Tbio Non-IDG -3.81741 7285.3 401
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86